The recent decision by the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), to classify the artificial sweetener Aspartame as “possibly carcinogenic to humans” has generated widespread alarm. (Tổ Chức Y Tế Thế Giới) However, much of the public reaction appears disproportionate — triggering undue fear rather than reasoned assessment.
First, it’s important to understand what the classification means. IARC placed aspartame in Group 2B, meaning there is “limited evidence” of carcinogenicity in humans. (Tổ Chức Y Tế Thế Giới) That does not equate to a definitive link between normal consumption and cancer. As experts noted, the classification addresses hazard (can it cause cancer under some conditions?) rather than actual risk (will it lead to cancer at typical exposure levels?). (sciencemediacentre.org)
Second, the regulatory body Joint FAO/WHO Expert Committee on Food Additives (JECFA) reaffirmed that the previously established acceptable daily intake (ADI) for aspartame of 0–40 mg/kg body weight remains safe. (Tổ Chức Y Tế Thế Giới) Thus, everyday use within those limits remains acceptable according to current science.
Yet media headlines and social media reactions have generally framed the news as a dramatic danger: “aspartame causes cancer,” “avoid diet drinks now,” etc. This kind of sensationalism risks creating panic rather than prompting thoughtful moderation. The result: unnecessary anxiety among consumers, potential stigmatization of products that help reduce sugar intake, and misallocation of public health attention away from higher‑priority risks (like obesity, smoking, alcohol).
In short: yes, the IARC classification is worth noting — science evolves — but the public response should be measured. The outrage over “unsafe aspartame” is largely misplaced, given the lack of convincing evidence at normal consumption levels and the strong regulatory safeguards in place. The focus ought to be on moderation, context, and keeping perspective — not alarm.
